Comerica Bank Organon & Co. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Organon & Co. stock. As of the latest transaction made, Comerica Bank holds 209,367 shares of OGN stock, worth $3.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

209,367

Previous 210,778 0.67%

Holding current value

$3.2 Million

Previous $4.36 Million 8.21%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.65 - $23.03 $26,315 - $32,495	-1,411 Reduced 0.67%	209,367 $4.01 Million
Q2 2024 Aug 15, 2024	BUY	$17.45 - $21.96 $1.47 Million - $1.85 Million	84,065 Added 66.34%	210,778 $4.36 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $30,316 - $41,360	2,200 Added 1.77%	126,713 $2.38 Million
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $725,032 - $1.15 Million	66,213 Added 113.57%	124,513 $1.8 Million
Q3 2023 Nov 21, 2023	BUY	$16.59 - $23.77 $353,682 - $506,752	21,319 Added 57.65%	58,300 $1.01 Million
Q2 2023 Aug 22, 2023	BUY	$19.27 - $24.63 $36,767 - $46,994	1,908 Added 5.44%	36,981 $3,000
Q4 2022 Jan 26, 2023	BUY	$23.31 - $28.61 $16,876 - $20,713	724 Added 2.11%	35,073 $0
Q3 2022 Oct 28, 2022	BUY	$23.4 - $34.25 $25,974 - $38,017	1,110 Added 3.34%	34,349 $825,000
Q2 2022 Aug 02, 2022	SELL	$31.66 - $38.9 $32,071 - $39,405	-1,013 Reduced 2.96%	33,239 $1.05 Million
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $172,834 - $223,407	-5,676 Reduced 14.22%	34,252 $1.2 Million
Q4 2021 Feb 18, 2022	SELL	$28.67 - $37.13 $117,604 - $152,307	-4,102 Reduced 9.32%	39,928 $1.22 Million
Q3 2021 Nov 22, 2021	SELL	$28.63 - $35.64 $931,133 - $1.16 Million	-32,523 Reduced 42.48%	44,030 $1.44 Million
Q2 2021 Aug 26, 2021	BUY	$28.45 - $38.0 $2.18 Million - $2.91 Million	76,553 New	76,553 $2.32 Million

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account